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Abstract 
It has been suggested that the transient receptor potential cation (TRP) channel subfamily V 
(vanilloid) type 4 (TRPV4) and intermediate-conductance calcium-activated potassium 
(KCa3.1) channels contribute to endothelium-dependent vasodilation. Here we summarize 
very recent evidence for a synergistic interplay of TRPV4 and KCa3.1 channels in lung 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
disease. Among the endothelial Ca2+-permeable TRPs, TRPV4 is best characterized and 
produces arterial dilation by stimulating Ca2+-dependent NO synthesis and endothelium-
dependent hyperpolarization. Besides these roles, some TRP channels control 
endothelial/epithelial barrier functions and vascular integrity, while KCa3.1 channels provide 
the driving force required for Cl- and water transport in some cells and most secretory 
epithelia. The three conditions, increased pulmonary venous pressure caused by left heart 
disease, high inflation pressure, and chemically-induced lung injury may lead to activation of 
TRPV4 channels followed by Ca2+ influx leading to activation of KCa3.1 channels in 
endothelial cells ultimately leading to acute lung injury. We find that a deficiency in 
KCa3.1channels protects against TRPV4-induced pulmonary arterial relaxation, fluid 
extravasation, hemorrhage, pulmonary circulatory collapse, and cardiac arrest in vivo. These 
data identify KCa3.1 channels as crucial molecular components in downstream TRPV4-
signal transduction and as a potential target for the prevention of undesired fluid 
extravasation, vasodilatation, and pulmonary circulatory collapse. 
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Introduction 
 Left heart disease and increased pulmonary venous pressures cause pulmonary 
oedema of cardiac origin. Non-cardiogenic acute lung injury and adult respiratory distress 
syndrome (ARDS) can also cause pulmonary oedema because of an increased permeability 
for salts, proteins, and water in the lung (Ranieri et al. 2012). In man, acute lung injury and 
ARDS are characterized by an acute onset of respiratory failure with bilateral infiltrates on 
chest x-rays, the absence of left atrial hypertension (pulmonary artery wedge pressure < 18 
mmHg), and pulmonary arterial oxygen pressure that in case of acute lung injury is less than 
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300 mmHg and in case of ARDS less than 200 mmHg (Ranieri et al. 2012). The 28 day 
mortality is approximately 25-30% of both acute lung injury and ARDS in man (Ware & 
Matthay 2000). Among the events leading to acute lung injury and ARDS, an inflammation 
with infiltration of immune cells and leakage of protein-rich fluid into interstitium and alveoli 
are of major pathomechanistic importance. The resulting lung oedema produces a diffusion 
mismatch, and shunting of the blood in the lung, finally leading to respiratory failure. Despite 
the presence of inflammation, the effect of steroids on the conditions is limited to less need of 
use of vasopressors, more ventilator and shock free days, less skeletal muscle weakness, and 
short-term improvement in oxygenation. However, the steroid treatment does seemingly not 
reduce mortality (Steinberg et al. 2006). Although some studies with small numbers of 
patients have shown potential benefit of e.g. inhaled prostacyclin, epoprostenol, and nitric 
oxide (NO), there is no convincing evidence to date that any of these drugs saves lives in 
acute lung injury and ARDS (Duggal et al. 2015, Searcy et al. 2015). Therefore, there is a 
clear need for novel therapeutic strategies for these conditions as well as a more profound 
understanding of the underlying pathophysiological mechanisms. 
The role of transient potential receptor channels vanilloid type 4 (TRPV4) channels in 
respiratory diseases has been reviewed recently (Goldenberg et al. 2015). Here we review 
new evidence for TRPV4 channels in endothelium-dependent vasodilatation in the pulmonary 
circulation and the role of these channels in lung oedema and pulmonary circulatory collapse. 
Finally, we review recent evidence showing that lung TRPV4 channels interact with 
countercurrent producing and membrane hyperpolarizing calcium-activated channels with 
intermediate conductance (KCa3.1) and that genetic deficit of these K channels in mice 
(KCa3.1-/-) is protective against TRPV4-induced pulmonary circulatory collapse and oedema. 
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Role of endothelial TRPV4 channels and KCa3.1 in endothelium-dependent 
vasodilatation 
The TRPV4 channel is a remarkable non-selective cation channel with considerable 
calcium conductance (PCa/PNa ≈ 8) that is gated poly-modally by chemical factors such 
endogenous arachidonic acid (AA) and eicosanoids (Table 1), as well as by physical forces 
e.g. osmotic stress and membrane stretch (Figure 1, (Clapham 2003)). It is well established 
that TRPV4 is expressed in the endothelium of systemic and renal arteries (Chen et al. 2015a, 
Kohler et al. 2006, Watanabe et al. 2003), and is likely to mediate Ca2+ entry in the 
endothelium in response to AA-release stimulating signals (Qian et al. 2014) and to sudden 
increases in hemodynamic forces such as flow and shear stress as it occurs during reperfusion 
(Hartmannsgruber et al. 2007, Kohler et al. 2006) as well as to abnormally high intracapillary 
pressure (Hamanaka et al. 2007, Yin et al. 2008). In the lung, TRPV4 channels are expressed 
in the bronchial epithelium, capillary endothelium, and in smooth muscle of extra-alveolar 
arterioles (Alvarez et al. 2006, Fernandez-Fernandez et al. 2008). By patch clamp we 
recently provided evidence for functional TRPV4 channels in native mouse pulmonary 
arterial endothelial cells (Wandall-Frostholm et al. 2015) and mRNA-expression studies 
suggest the presence of TRPV4 in both, the endothelium and smooth muscle layer of rat large 
pulmonary arteries (Sukumaran et al. 2013). This is further supported by immunohistological 
proof of TRPV4 protein in both media and intima of pulmonary arteries in rats (Pankey et al. 
2014). However, it remains to be elucidated, which humoral stimulus and/or 
chemical/physical forces that lead to activation of the TRPV4 channels in the pulmonary 
circulation. Indeed, mechanical stretch during respiration has been proposed to activate 
stretch-sensitive channels (Goldenberg et al. 2015), and TRPV4 is likely to act as such a 
mechanosensitive channel in the lung. 
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In addition to mechanical stimulation, formation of epoxyeicosatrienoic acids (EETs) 
from their precursor AA has been suggested to activate TRPV4 channels (Vriens et al. 2004, 
Watanabe et al. 2003).Agonist-induced stimulation with acetylcholine also leads to TRPV4 
activation and Ca2+ entry causing vasodilatation that is mediated by the two major endothelial 
vasodilator systems, the Ca2+-dependent endothelial nitric oxide synthase (eNOS) (Kohler et 
al. 2006) and the endothelium-derived hyperpolarization (EDH) pathway as concluded from 
studies in carotid and mesenteric arteries from mice and rats (Hartmannsgruber et al. 2007, 
Sonkusare et al. 2012, Sonkusare et al. 2014). Yet, there is no clear evidence that TRPV4 
channels contribute to the physiologic regulation of systemic blood flow and pressure as 
concluded from the normal/low systemic blood pressure in TRPV4-deficient mice (Earley et 
al. 2009). Nonetheless, pharmacological activation of TRPV4 by systemic administration of 
the potent TRPV4-activators GSK1016790A and 4α-phorbol-12,13-didecanoate (4αPDD) 
produces a strong drop in systemic blood pressure in mice, rats, and dogs (Pankey et al. 2014, 
Willette et al. 2008). In the pulmonary circulation activation of TRPV4 channels by 
GSK1016790A was initially suggested to lead to vasoconstriction (Willette et al. 2008). In 
the intact-chest rat model infusion of GSK1016790A only evoked constriction in the 
pulmonary circulation after treatment with the NO synthase inhibitor, N-nitro-L-arginine, 
while low doses of GSK1016790A in the absence of NO synthase inhibitor, caused small 
decreases in pulmonary arterial pressure (Pankey et al. 2014). In isolated constantly perfused 
mouse lungs, GSK1016790A increased pressure suggesting that it induced vasoconstriction 
(Ke et al. 2015). However, as previously pointed out by others a major limitation of these 
studies were that they were performed in perfused lungs without ventilation (Gollasch & 
Kubler 2016). In isolated pulmonary arteries, blockade of TRPV4 channels inhibited 5-
hydroxytryptamine-induced contraction (Xia et al. 2013, Yang et al. 2012), and in murine 
pulmonary arteries without endothelium, GSK1016790A increased contractions induced by 
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phenylephrine suggesting that smooth muscle TRPV4 channels were involved in the 
contraction (Wandall-Frostholm et al. 2015). In chronic hypoxic rats expression of TRPV4 
channels is increased and contributes to the increased 5-hydroxytryptamine-induced 
contraction in the pulmonary arteries (Yang et al. 2012). Moreover, it has been suggested that 
TRPV4 channels may also contribute to acute hypoxic vasoconstriction in the lung (Morty & 
Kuebler 2014), implying that these channels may play a role in the von Euler-Liljestrand 
mechanism, where the blood is redistributed by vasoconstriction from poorly to better 
ventilated lung areas. In addition to TRPV4 channels, TRPV2 channels have been proposed 
to contribute to acute hypoxic vasoconstriction (Yoo et al. 2012), and therefore, further 
studies are warranted to clarify the role of smooth muscle TRPV4 channels in the von Euler-
Liljestrand mechanism.   
In addition to functional smooth muscle TRPV4 channels, TRPV4 channels in the 
endothelium play an important role in the pulmonary circulation (Figure 2). In rat pulmonary 
arteries contracted with phenylephrine, increasing concentrations of GSK1016790A caused 
endothelium-dependent relaxations (Sukumaran et al. 2013), and these relaxations were 
presumably mediated both by NO and activation of calcium-activated K channels 
(Sukumaran et al. 2013). In isolated pulmonary arteries from mice, GSK1016790A also 
caused endothelium-dependent relaxations that were sensitive to a selective blocker of 
TRPV4 channels, HC067047. Moreover, GSK1016790A relaxations were reduced by 
inhibition of NO synthase and by KCa3.1 deficiency in pulmonary arteries from KCa3.1-/- 
mice. The impairment of the GSK1016790A relaxations was more pronounced in more distal 
intrapulmonary arteries from KCa3.1-/- mice (Wandall-Frostholm et al. 2015). These studies 
suggest that activation of TRPV4 channels in the proximal pulmonary arteries mainly leads to 
relaxations mediated by NO, while in distal smaller arteries, TRPV4 channel activation leads 
also to activation of the EDH pathway. This was also supported by our observations that 
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inhibition of NO synthase inhibited only weakly the blood pressure lowering effects of 
infused GSK1016790A in the mouse pulmonary lung. In contrast, KCa3.1 channel deficiency 
in KCa3.1-/- mice prevented this pressure drop (Wandall-Frostholm et al. 2015) suggesting a 
major role of KCa3.1-activation in here. Indeed, in patch-clamp studies in freshly isolated 
pulmonary arterial endothelial cells we found that GSK1016790A co-activated KCa3.1 and 
also to a minor extent small conductance calcium-activated K channels (KCa2) (Wandall-
Frostholm et al. 2015). It has also been shown that TRPV4-induced endothelial Ca2+ events 
(sparklets) are capable of activating co-localized KCa3.1 in mesenteric resistance arteries 
(Sonkusare et al. 2012). Thus, from the cell biological perspective, our and previous findings 
prove functional synergism of the two channels. 
The finding of a major role of KCa3.1 in endothelial vasodilator function in the 
pulmonary arteries is in line with previous findings in other vascular beds showing impaired 
EDH- and NO-type relaxations to acetylcholine in the cremaster microcirculation and in large 
carotid arteries of KCa3.1-/- mice (Hasenau et al. 2011, Si et al. 2006, Wolfle et al. 2009).  
As already indicated above, KCa3.1 is apparently co-expressed with the 
calcium/calmodulin-gated KCa2.3 subtype (a close phylogenetic relative with smaller 
conductance) in pulmonary arterial endothelium and the endothelium of systemic vessels 
(Brahler et al. 2009, Edwards et al. 1998, Kroigaard et al. 2012). The presence of the two 
channels is explained by the fact that they serve different physiological functions: in isolated 
mesenteric arteries KCa2.3 channels were suggested to exert a more tonic hyperpolarizing 
and vasodilating impact while the role of KCa3.1 channels is to help repolarizing the 
endothelium (Crane et al. 2003).  Moreover, KCa3.1 channels are particularly responsive to 
acetylcholine-induced calcium-release from IP3-sensitive stores  promoting subsequent 
calcium-entry through TRPV4 channels (Qian et al. 2014), and initialization of EDH-type 
dilatations in murine arteries. However, in isolated human and murine pulmonary arteries and 
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bronchioles KCa2.3 channels seem to be more important than KCa3.1 for EDH dilations as 
concluded from the stronger inhibitory effect of the KCa2 blocking toxin apamin on 
relaxations produced by an unselective opener, NS309 of KCa3.1 and KCa2 channels 
(Kroigaard et al. 2012, Wandall-Frostholm et al. 2014). Also another blocker of KCa2 
channels, UCL1618, inhibits strongly the relaxations following pharmacological opening of 
TRPV4 in mouse pulmonary arteries, although the contributions of KCa2 channels to current 
is small in pulmonary endothelial cells from wild type animals,  but appreciable in pulmonary 
artery endothelial cells from KCa3.1-deficient mice (Wandall-Frostholm et al. 2015).  
Therefore, the physiological role of activation of KCa2.3 by TRPV4 channel opening in the 
lung remains to be clarified. 
 
Role of TRPV4 in pulmonary vascular collapse and lung oedema 
There is emerging evidence suggesting that stretch activation of TRPV4 channels 
followed by pulmonary vascular pressure-mediated Ca2+ uptake is involved in acute lung 
injury (Figure 3). Alvarez and colleagues found that disruption of the lung and perivascular 
and alveolar liquid accumulation following stimulation with the TRPV4-activators, 4-αPDD 
and 14,15 EET, was reduced in mice deficient of TRPV4 channels, while this was not the 
case for lung injury induced by calcium overload that was evoked by thapsigargin-induced 
endoplasmic reticulum calcium depletion (Alvarez et al. 2006). Moreover, in isolated lungs, 
high intravascular pressure is associated with increased endothelial cell calcium and alveolar 
liquid accumulation, effects, which were not present in lungs from TRPV4-/- mice and were 
blocked by inhibition of P450 epoxygenase or by blocking TRPV4 channels with ruthenium 
red (Jian et al. 2008, Yin et al. 2008). However, it is also worth mentioning that increases of 
cyclic GMP caused by either NO donors or by inhibition of phosphodiesterase type 5 with 
sildenafil were likewise capable of preventing oedema and the capillary endothelial calcium 
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overload in lungs of rats with acute failure of the left ventricle after induction of a large 
myocardial infarction (Yin et al. 2008). Intriguingly, the novel potent TRPV4 blocker, 
GSK2193874, inhibited oedema in isolated lungs generated by high pulmonary venous 
pressure in mice and was also found to be efficient in preventing lung oedema in a murine 
myocardial infarction model (Thorneloe et al. 2012). These data from preclinical 
investigations suggest a role for TRPV4 channel activation and increased endothelial calcium 
in lungs exposed to sudden increases of high hydrostatic intravascular pressure, and that 
TRPV4 channel blockers may have efficacy in at least lung oedema with cardiac origin. 
Interestingly, in a rat model of chronic congestive heart failure (supracoronary aortic 
banding) impairment of pulmonary endothelium-dependent vasodilatation and endothelial 
cell calcium responses were observed in response to mechanical stress and agonist 
stimulation, and these alterations were associated with downregulation of TRPV4 channel 
expression (Kerem et al. 2010). The authors also found reduced NO formation and marked 
cytoskeletal reorganization in the endothelial cell layer (Kerem et al. 2010), suggesting that 
in chronic heart failure of the left ventricle, the pulmonary vasculature adapts by functional 
and morphological remodeling to increased pulmonary pressure.  
 
 Ventilation by use of a respirator can at least in certain conditions (e.g. high peak 
inflation pressure or by high end expiratory pressure) lead to lung injury in human subjects 
(Neto et al. 2015). In isolated mouse lungs exposed to either low or high peak inflation 
pressure, the pulmonary filtration coefficient (Kf) was increased in the mouse lungs exposed 
to high peak inflation pressure, but this was not the case in lungs from TRPV4-/- mice, and the 
effect of high inflation pressure was also blocked by ruthenium red (Hamanaka et al. 2007). 
The effect of high inflation pressure may, in addition to activation of TRPV4 channels in the 
epithelium and endothelium, also lead to activation of TRPV4 channels in macrophages, 
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since instillation of macrophages from TRPV4+/+ mice markedly increased Kf in isolated 
lungs from TRPV4-/- mice (Hamanaka et al. 2010).   
Chemical and acid exposure e.g. by aspiration of gastrointestinal content can produce 
non-cardiogenic acute lung injury and ARDS. In mice instillation of HCl or inhalation of 
chlorine were associated with infiltration of the lungs with macrophages and neutrophils and 
a worsening of the lung damage in TRPV4+/+ mice, while these effects were absent in lungs 
from TRPV4-/- mice (Balakrishna et al. 2014). Administration of two selective TRPV4 
channel inhibitors after exposure to HCl or chlorine, also reduced infiltration of  macrophages 
and neutrophils, reduced the elevated levels of cytokines, and improved the histopathological 
score (Balakrishna et al. 2014). However, a recent study reported only a prophylactic effect 
of GSK2193874 against acid-induced acute lung injury and infiltration of neutrophils in 
murine lungs, while there was no effect of another TRPV4 blocker, HC067047 against lung 
injury (Yin et al. 2016). Still, the expression of TRPV4 channels in both macrophages and 
neutrophils opens the possibility/perspective that blockade of these channels may reduce 
tissue damage caused by e.g. lung infection and damaging chemical substances. 
 
 In summary, TRPV4 channels appear to be involved in acute lung injury caused by 
increased hydrostatic pressure due to left heart disease, high inflation pressure, and 
chemically induced lung injury. These preclinical studies clearly suggest that there could be a 
potential for use of TRPV4 channel blockers for treatment of patients with acute lung injury. 
The treatment may be safe as concluded from animal studies, in which TRPV4 channels 
blockers do not seem to possess obvious adverse cardiovascular effects. However, it remains 
to be clarified whether these blockers inhibit the Euler-Liljestrand mechanism as previously 
proposed (Morty & Kuebler 2014), and hence the redistribution of blood from hypoxic to 
oxygenated areas in the lung which could be devastating due to even lower blood oxygen 
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saturation levels in lung injury. Thus, pharmacological TRPV4 blockade in contrast to 
pharmacological TRPV4 activation appears to be safe, although this still needs to be proven 
experimentally. 
 
Protective role of genetic deficit of KCa3.1 against TRPV4-induced pulmonary 
circulatory collapse and oedema  
In normal physiological conditions osmotically-driven water transport across cell 
membranes is thought to be the principle mechanism of fluid transport. In the lung, it has 
been suggested that water channels, aquaporins, and especially aquaporin 4 and 5 are 
important for liquid clearance in the alveoles, while in lung microvascular endothelium 
aquaporin 1 is considered the main predominantly expressed water channel (Verkman 2007). 
However, mice deficient of either aquaporin 1, 4, or 5 accumulate liquid in the lung to similar 
levels as control mice in response lung injury (Song et al. 2000). However, the slow rates of 
fluid transport support that aquaporins may add only marginally to transepithelial water 
transport in the lungs (Verkman 2007). In heart failure pressure-driven bulk fluid flow 
produces lung edema and pleural effusions (Berthiaume & Matthay 2007, Verkman 2007), 
while in lung injury (ALI and ARDS) there is pulmonary permeability edema and it can be 
accompanied by (Lucas et al. 2009): (1) reduction of alveolar liquid clearance capacity, 
thought to be caused by an inhibition of the expression of crucial sodium transporters (ENac), 
the cyclic AMP-regulated cystic fibrosis transmembrane regulator chloride channel (CFTR),  
and the Na+K+-ATPase (Figure 3), (2) an endothelial/epithelial hyperpermeability, which to a 
large degree is cytokine induced, and (3) a disruption of the epithelial and endothelial barriers 
caused by increased apoptosis and necrosis. As mentioned above TRPV4 channels appear to 
play a role both in cardiac and lung jnjury-induced oedema, and the coupling of the TRPV4 
activation to KCa3.1 channels seems to be important. 
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To remind the reader, the KCa3.1 channel is a calcium-activated K channel of 
intermediate-conductance (20-40 pS) that is activated by calcium-binding to calmodulin that 
is constitutively bound to the cytosolic c-terminus and acts as the Ca2+ sensing beta-subunit 
of the channels (EC50, 250-500 nM). KV channels and the KCa1.1 channels have a voltage 
sensor that causes channel inactivation at negative membrane potentials, but this is not the 
case for the KCa3.1 channel which lacks a voltage sensor. This enables the channel, unlike 
KV channels, to produce solid and lasting hyperpolarization up to the K channel equilibrium 
potential of around -89 mV. KCa3.1 is found in several white blood cell linages, in 
erythrocyte (Gardos channel) and in most secretory epithelia where KCa3.1 channels play 
important roles in the control of fluid movements because K efflux through the channel and 
concomitant hyperpolarization provide the electrical driving force for chloride efflux through 
apical Cl- channels (occurring at potentials more negative than the chloride equilibrium 
potential of around -30-50 mV in epithelia) and concomitant water movements. This could be 
an important mechanism in airway epithelia and other epithelia, in which presumably 
basolateral located KCa3.1 channels functionally interplays with the apical CFTR chloride 
channel, and Ca2+-activated Cl- channels (CaCC encoded by the TMEM16A gene) to enable 
transepithelial chloride and water secretion in response to stimuli triggering cAMP-elevations 
and increase of intracellular Ca2+ (Bertuccio et al. 2014, Mall et al. 2003, Vazquez et al. 
2001). Thereby, KCa3.1 channels could pivotally contribute to the control of mucus 
production and its stickiness in the airways and to transepithelial chloride and water transport 
as previously described for gastric and intestinal epithelia as well as exocrine salivary glands 
(Catalan et al. 2014). Therefore, KCa3.1 channel blockade, deficiency or downregulation 
could be strategies to prevent excessive transepithelial fluid transport caused by 
pathologically high pressures in the pulmonary arterial and venous circulation. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Phenotyping of KCa3.1 gave important information about the in-vivo roles of the 
channel. Concerning erythrocytes, in which KCa3.1 is known to be involved in the control of 
cell volume, we found that KCa3.1-deficiency produced subtle macrocytosis (a sign of mild 
overhydration and fragility) and progressive splenomegaly as the perhaps an anatomical  
“visible” phenotype (Grgic et al. 2009). Considering the large body of literature regarding the 
role of T cell KCa3.1 in the immune response, it is interesting to realize that the KCa3.1-/- 
mice are generally not immune suppressed. With respect to the systemic circulation, 
deficiency of KCa3.1 channels leads to a significant increase in pulse pressure and a mild 
elevation of systolic blood pressure exclusively during physical activity with no change in 
diastolic pressure (Si et al. 2006).  Regarding alterations in the pulmonary system, we have 
studied a series of lung parameters in KCa3.1-/- mice and wild type mice. By use of a 
flexiVent system (SCIREQ Inc, Montreal, Qc, Canada) we fitted dynamic pressure-volume 
loops to a single compartment model to calculate system resistance and elastance, and by use 
of the forced oscillation technique data were fit to the constant phase model to calculate 
central airway resistance and tissue elastance and tissue damping as previously described 
(McGovern et al. 2013, Phillips et al. 2012). Tracheal instillation of bleomycin markedly 
increased system and tissue elastance, reflecting increased stiffness in these functional lung 
fibrosis parameters both in wild type and KCa3.1-/- mice (Figure 4), and the changes in other 
respiratory parameters also changed similarly in wild type and KCa3.1-/- mice suggesting that 
these patophysiological changes were independent of the KCa3.1 channel.  Considering 
ventricular and pulmonary pressure, the right ventricular pressure is unaltered in KCa3.1-/- 
mice (Wandall-Frostholm et al. 2015). Moreover, the combination of complete lack of 
KCa3.1 and reduction of KCa2.3 expression in KCa3.1-/-/KCa2.3T/TDox mice (Brahler et al. 
2009) did not alter pulmonary hypertension although there were structural changes of the 
heart (increased right ventricular wall thickness) and larger pulmonary arteriole lumen 
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diameters in this strain compared to wild-type mice (Wandall-Frostholm et al. 2014), which 
are presumably caused by the manipulation of the KCa2.3 expression levels rather than by 
KCa3.1-deficiency.  
 Importantly, we found that following infusion of the TRPV4 opener GSK106790A, 
KCa3.1-/- mice were protected against lung hemorrhage and lung oedema as concluded from 
histological examination and measurements of perivascular cuffing and widening of 
extravascular spaces in the lung (Wandall-Frostholm et al. 2015). Moreover, infusion of 
GSK106790A caused vascular collapse and death in wild type mice, but not in KCa3.1-/- 
mice. Recent findings further support this concept by showing that in the isolated rat lung, 
infusion of the endogenous TRPV4-activators, EETs increase the filtration coefficient, an 
effect prevented by blocking KCa3.1 channels with TRAM-34 (Lin et al. 2015). This 
suggests that activation of KCa3.1 channels plays a pivotal role in fluid extravasation in the 
lung induced by TRPV4 activation as outlined in Figure 3. Thus, we speculate that the three 
conditions, 1) increased pulmonary venous pressure caused by left heart disease, 2) high 
inflation pressure, and 3) chemically-induced lung injury activate calcium influx through 
TRPV4 in the lung  endothelium/epithelium that in turn triggers opening of KCa3.1 channels. 
The concomitant hyperpolarization generates a positive feed-back loop on calcium influx 
through TRPV4 channels while at the same time the hyperpolarization provides a sufficiently 
negative membrane potential to push also negatively charged chloride through chloride 
channels out of the cells. These movements of K and Cl force water to follow and to 
accumulate in the interstitium and alveoli. There are several pieces of additional evidence 
supporting this concept. 1) When comparing the ratios of dry weight and wet weight as a 
measure of water content between genotypes, we found that the ratios were higher (indicative 
of liquid accumulation) in wild type lungs exposed to the TRPV4 channel opener, 
GSK106790A, than in lungs from KCa3.1-/- mice (Figure 5). 2) Liquid accumulation 
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measured as cuffs around extra-alveolar vessels or widening of extracellular space in 
histological sections were increased in response to GSK106790A in wild type mice, but these 
effects were markedly reduced in KCa3.1-/- mice (Wandall-Frostholm et al. 2015). 3)We 
found that TRAM-34 was able to prevent TRPV4-induced cell swelling and to reduce 
membrane blebs in endothelial cell cultures, again suggesting that K efflux through KCa3.1 
channels plays a role in endothelial cell integrity and barrier function (Figure 3, (Wandall-
Frostholm et al. 2015). 
ARDS is characterized by leakage of protein-rich oedema fluid, and this is mimicked 
by activation of the TRPV4 channel and is absent in TRPV4 -/- mice (Alvarez et al. 2006). In 
the KCa3.1-/- mice, we investigated protein extravasation by using Evans blue and found a 
massive accumulation of Evans blue in the lungs from both wild type and KCa3.1-/- mice. 
There was no obvious difference between the genotypes (Wandall-Frostholm et al. 2015). 
These findings suggest that the KCa3.1 channel plays a pivotal role at least for interstitial 
fluid accumulation and vascular collapse leading to death following pharmacological TRPV4 
channel activation. As mentioned earlier, TRPV4 channel blockade prevents infiltration with 
neutrophils and macrophages in lung injury in mice (Yin et al. 2016), but at present it is 
unclear whether infiltration of immune cells in the lung is affected by KCa3.1 channel 
deficiency. 
In summary, the findings that TRPV4 channels play a role in both cardiac and non-
cardiac lung oedema suggest that, TRPV4 channel activation, in addition to perhaps reduced 
alveolar liquid clearance by ENac, CFTR, and Na+K+-ATPase, mediate rapid liquid 
extravasation by coupling to the KCa3.1 channels and likely to calcium-activated chloride 
channels (CaCC) to produce potassium and chloride outflow, and concomitant fluid 
movement into the interstitium and alveoli (Figure 3).   
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Do KCa3.1 blockers have therapeutic utility against pulmonary circulatory collapse and 
oedema? 
Based on our studies in mice KCa3.1-/- mice (Wandall-Frostholm et al. 2015), 
blockade of KCa3.1 could be a strategy to prevent excessive transepithelial fluid transport 
caused by pathologically high pressures in the pulmonary arterial and venous circulation. In 
such a scenario, selective blockers of KCa3.1 such as TRAM-34, Senicapoc (ICA-17043), 
cyclohexadienes (Mauler et al. 2004) or the novel negative-gating modulator, the dibenzoate 
ester, RA-2 (Olivan-Viguera et al. 2015) may prevent lung oedema formation when applied 
from the bronchial side to minimize potential systemic effects on blood pressure. While this 
is hypothetical for the lung, there are studies on the brain that suggest such utilities for 
prevention of oedema: A cyclohexadiene compound efficiently reduces brain oedema in a rat 
acute subdural haematoma model (Mauler et al. 2004). TRAM-34 has been shown to block 
blood-brain-barrier KCa3.1 and thereby sodium-uptake to the affected brain areas after 
ischemic stroke (Chen et al. 2015b). Therefore, a series of preclinical studies have to be 
conducted to explore the possibility of using KCa3.1 blockers for treatment of pulmonary 
oedema and vascular collapse. Moreover, it is required to address whether combined 
blockade of KCa2 and KCa3.1 channels provide additional beneficial effect, and whether 
blockade of KCa3.1 channels provide similar or better outcome compared to TRPV4 channel 
blockade in the treatment of pulmonary oedema and collapse. 
Drugs for treating pulmonary oedema of cardiac origin (acute heart failure) are 
diuretics, positive inotropic drugs (e.g. levosimendan, dobutamine, dopamine), and 
depending on the systemic blood pressure also vasodilators according to the guidelines of the 
European Society of Cardiology (McMurray et al. 2012). In keeping with the potential roles 
of TRPV4 channels in lung oedema with cardiac origin, it is thinkable that specific blockade 
of these channels may resolve or help to resolve the condition. Concerning KCa3.1 channels 
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it remains to be clarified whether they represent potential drug targets in pulmonary oedema 
of cardiac origin.   
Treatment with KCa3.1 blockers affects hematological parameters. In mice, treatment 
with TRAM-34 (120 mg/kg/day, i.p.) over 4 weeks produced mild splenomegaly (142% of 
control) and hepatomegaly (+153%) and improved erythrocyte hemoglobin content and 
hematocrit, although the treatment caused a decrease in erythrocyte count (-8 %) and an 
increase in reticulocyte count (+66 %). The treatment did not cause erythrocyte macrocytosis 
but led to a significant increase in red blood cell distribution width (Köhler, unpublished 
observations), suggesting alterations in erythrocyte volume regulation in mice. Another 
KCa3.1-blocker, Senicapoc, advanced into clinical trials for sickle cell disease and was found 
to increase hemoglobin levels and reduce hemolysis although it failed to reach the primary 
endpoint, a reduction in painful vaso-oclusive crisis. Yet, a 12-week treatment with the 
compound was found to be safe in humans at a peroral dosage of 10 mg/day (Ataga et al. 
2008). Although this drug at first sight appears clinically safe, additional safety studies will 
be required before repurposing this drug or using other drug candidates for treating patients 
with the above-mentioned lung conditions. 
Small molecule activators of the KCa2 and KCa3.1 channels such as DC-EBIO, 
NS309, and the more KCa3.1-selective SKA-121 may have therapeutic potential in cystic 
fibrosis, chronic obstructive pulmonary disease (COPD), and in other diseases characterized 
by impaired secretory activity (Christophersen & Wulff 2015, Coleman et al. 2014, Kroigaard 
et al. 2012, Syme et al. 2000). However, with respect to the lung, there are some concerns 
regarding the utility of KCa3.1 activators because they may bear the risk to promote oedema 
formation by stimulating transepithelial Cl- secretion, fluid extravasation, and alveolar 
flooding. 
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Table 1. Characteristics of transient receptor potential vanilloid type 4 (TRPV4) and 
calcium-activated potassium channels with intermediate conductance (KCa3.1). 
                            TRPV4  
 
                             KCa3.1 
Conductance 30-60 pS at -60 
mV 
Ca2+>Mg2+>K+> 
Cs+>Rb+>Na+>Li+
11-40 pS K+>Rb+>NH4+>Cs+
Activators  
4αPDD 
GSK1016790A 
RN1747 
*EC50 (µM) 
0.32 
0.002-0.02 
0.79 
 
NS309 
SKA-121 
DC-EBIO 
EC50 (µM) 
0.01 
0.10 
4.1-4.5 
Blockers  
HC067047 
GSK2193874 
RN1734 
EC50 (µM) 
0.016-0.13 
0.002-0.02 
2.0-6.3 
 
TRAM-34 
Charybdotoxin 
Senicaproc 
pEC50 (µM) 
0.01-0.025 
0.002-0.025 
0.01 
Endogenous 
activators 
EETs 
NO mediated 
S-nitrosylation 
 Intracellular 
calcium 
EC50 (µM) 
0.1-0.79 
EC50, concentrations causing half maximal effect. *, range of pEC50 depends on species 
where the compounds have been tested. EETs, epoxyeicosatrienoic acid; 4αPDD, 4α-phorbol 
12,13-didecanoate; NO, nitric oxide. Further details on the channels can be found on the 
following address: www.guidetopharmacology.org  
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Legends 
Figure 1. Structure and regulation of TRPV4 channel.  
Figure 2. Scheme showing calcium influx through TRPV4 channels in endothelial cell 
(E) followed by activation of calcium-activated potassium channels (KCa2.3 and 
KCa3.1) and endothelial nitric oxide synthase (eNOS).  The potassium released from the 
endothelial cells leads to increased Na+/K+-ATPase activation and smooth muscle 
hyperpolarization while NO stimulates soluble guanylyl cyclase (sGC), formation of cyclic 
GMP and opening of smooth muscle large conductance calcium-activated potassium channels 
(KCa1.1). The resulting hyperpolarization reduce calcium influx through voltage-gated L-
type calcium channels and relaxation of the underlying smooth muscle layer. Opening of the 
TRPV4 channels in the smooth muscle may occur during inhibition of eNOS activity.  
Figure 3. Hypothetical role of blood-alveolar lung KCa3.1 channels in oedema 
formation during involvement of TRPV4 channels. (A) The three conditions, increased 
pulmonary venous pressure due to acute left heart disease (ΔP), high inflation pressure, and 
chemically-induced lung injury leads to activation of transient receptor potential vanilloid 
type 4 channels (TRPV4). This activation produces permeability of the endothelial (E) cell 
layer and protein and liquid accumulation in the alveoles. (B) The scheme shows the 
mechanisms involved in the endothelial-alveolar barrier (alveolar epithelial type I (AEI) and 
type II (AEII) cells). Here calcium influx through TRPV4 channels activates calcium-
activated potassium channels (KCa3.1) which in turn produce hyperpolarization and 
promotes in terms of a positive-feed-back loop additional calcium influx in endothelial cells 
and AEI and AEII. Moreover, the hyperpolarization provides the driving force for chloride 
efflux through Ca2+-activated Cl- channels (CaCC) and cyclic AMP-regulated cystic fibrosis 
transmembrane regulator chloride channel (CFTR) causing extracellular liquid accumulation. 
The liquid clearance by sodium transport through the ENaC channel and the CFTR is reduced 
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in both AEI and AEII cells.  Water may diffuse paracellularly. Aquaporins in the 
endothelial/epithelium may be of less importance. White blood cells (WBC) including both 
macrophages and neutrophils may act as mediators of inflammatory responses and thereby 
contribute to the pathophysiological processes by further accelerating the endothelial 
dysfunction and barrier disruption.  RBC, red blood cells. 
Figure 4. Lung parameters measured in wild type (wt) and KCa3.1 channel deficient 
(KCa3.1-/-) mice by use of forced oscillatory pressure. Respiratory system elastance (A) 
and tissue elastance (B) measured as changes in pressure achieved per unit change in volume 
or stiffness in mice 2 weeks after tracheal instillation of vehicle or the lung fibrosis-inducing 
drug, bleomycin. There were no differences comparing parameters in wild type and KCa3.1-/-
. The results are means±s.e.m. of 8-10 mice. *P<0.05 versus control mice compared with 2-
way analysis of variance. There was no interaction. 
Figure 5. Accumulation of extracellular liquid is inhibited in lungs from KCa3.1-/- mice. 
GSK1016790A was infused and the wet weight was obtained, and expressed as ratio of the 
dried lung weight (W/D). The dry weight was obtained after the tissue has been dried in a 
microwave oven for four days. *P<0.05 versus GSK1016790A-infused wild type mice (n=4). 
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